Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

Obesity is among the leading causes of morbidity and mortality worldwide and its
prevalence continues to increase globally. Because obesity is a chronic, complex, and …

Postprandial glucose, together with related hyperinsulinemia and lipidaemia, has been
implicated in the development of chronic metabolic diseases like obesity, type 2 diabetes …

The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2
diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study …

The mechanisms for controlling food intake involve mainly an interplay between gut, brain,
and adipose tissue (AT), among the major organs. Parasympathetic, sympathetic, and other …

Objectives: This study aims to explore the weight loss effect and safety of semaglutide as a
conventional anti-obesity drug systematically in obese or overweight patients without …

The ion channel TRPV1 is involved in a wide range of processes including nociception,
thermosensation and, more recently discovered, energy homeostasis. Tightly controlling …

The prevalence of obesity continues to grow rapidly worldwide, posing many public health
challenges of the 21st century. Obese subjects are at major risk for serious diet-related …

Background: Recent studies indicate that glucagon-like peptide (GLP)-1 inhibits appetite in
part through regulation of soluble leptin receptors. Thus, during weight loss maintenance …

The European Association for the Study of Obesity (EASO) considers obesity to be a health,
research, and societal priority [1]. It promotes the study of obesity. Moreover, the EASO …